To ask the Secretary of State for International Development, whether it is her Department's policy to implement the recommendation in the report by the UN High Panel of Access to Medicines, Promoting innovation and access to health technologies, published in September 2016, on improving standards of transparency in the pharmaceutical industry.
Answered on
7 December 2016
While we support the aims of the UN High Level Panel on Access to Medicines, we note that this panel of experts could not reach consensus. DFID supports improving transparency in the pharmaceutical industry and funds the Access to Medicine Index to increase the transparency of pharmaceutical companies.
Answered by
Department for International Development
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.